Stay updated with breaking news from Ken Song. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
American multinational pharmaceutical company Bristol Myers Squibb on Tuesday said it would buy RayzeBio for about $4.1 billion to bolster its cancer drug business
EconoTimes is a fast growing non-partisan source of news and intelligence on global economy and financial markets, providing timely, relevant, and critical insights for market professionals and those who want to make informed investment decisions.
The acquisition will bolster the pharma giant's cancer drug portfolio.
EconoTimes is a fast growing non-partisan source of news and intelligence on global economy and financial markets, providing timely, relevant, and critical insights for market professionals and those who want to make informed investment decisions.
RayzeBio is building a large factory on the northwest side of Indianapolis to make radioisotopes for cancer treatment.